Literature DB >> 14074476

PROTHROMBIN-TIME AND THROMBOTEST IN INJURED PATIENTS ON PROPHYLACTIC ANTICOAGULANT THERAPY.

S SEVITT, D INNES.   

Abstract

Entities:  

Keywords:  ANTICOAGULANTS; BLOOD COAGULATION TESTS; BURNS; FEMORAL FRACTURES; FRACTURES; GERIATRICS; HIP; LEG INJURIES; PHENINDIONE; PROTHROMBIN TIME; THROMBIN; WOUNDS AND INJURIES

Mesh：

Substances：

Year:  1964        PMID： 14074476     DOI： 10.1016/s0140-6736(64)92218-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

1.  LABORATORY STUDIES ON PATIENTS RECEIVING ANTICOAGULANT THERAPY.

Authors:  S SHAW; G D PEGRUM; S WOLFF
Journal:  J Clin Pathol       Date:  1965-05       Impact factor: 3.411

2.  A Trial of Clorindione-A Long Acting Oral Anticoagulant.

Authors:  D A King
Journal:  Postgrad Med J       Date:  1965-12       Impact factor: 2.401

3.  Assessment of short-anticoagulant administration after cardiac infarction. Report of the Working Party on Anticoagulant Therapy in Coronary Thrombosis to the Medical Research Council.

Authors: 
Journal:  Br Med J       Date:  1969-02-08

4.  Assessment of anticoagulant treatment of venous thromboembolism.

Authors:  W W Coon; P W Willis; M J Symons
Journal:  Ann Surg       Date:  1969-10       Impact factor: 12.969

5.  Thromboembolism and its prevention.

Authors:  S Sevitt
Journal:  Proc R Soc Med       Date:  1968-02

6.  Prophylaxis of pulmonary embolism.

Authors:  N L Browse
Journal:  Br Med J       Date:  1970-06-27

7.  Therapeutic ranges in anticoagulant administration.

Authors:  L Poller
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-08

8.  Prevention of postoperative deep venous thrombosis and pulmonary embolism.

Authors:  A E Carter; R Eban; R D Perrett
Journal:  Br Med J       Date:  1971-02-06

Review 9.  Antithrombotic drugs: part I.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

10.  AN INVESTIGATION OF THE HEMORRHAGIC DIATHESIS IN PATIENTS RECEIVING COUMARIN AND INDANEDIONE ANTICOAGULANTS.

Authors:  C W BAUGH
Journal:  Can Med Assoc J       Date:  1965-01-16       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.